01 1Cipla
01 1RITONAVIR USP
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2014-05-28
Pay. Date : 2013-04-05
DMF Number : 26443
Submission : 2013-01-11
Status : Active
Type : II
20
Cipla Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is RITONAVIR USP, with a corresponding US DMF Number 26443.
Remarkably, this DMF maintains an Active status since its submission on January 11, 2013, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 28, 2014, and payment made on April 05, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II
